Chantix May Help Curb Yen for Alcohol. What Would the DTC Ad Look Like?
A study reported in the LA Times suggested that Chantix appears to reduce the desire for alcohol as well as for smoking (see "Anti-smoking...
Not Since 1975 Have We Seen Job Losses Like This!
"The economy lost 2.1 million jobs in the past three months, equal to a staggering 1.6% of the entire work force," said Charles Biderman,...
You Must Score Better than 84% on Viagra’s Sexual Health Quiz to NOT Have...
I've noticed that many drug brand web sites are frequently updated. Most often, new video ads are added. Sometimes, as with the case of...
The The Impotence of Proofreading
Just thought all you blaggers out their wood learn alot from this vidio:via videosift.com
Tooting My Own Horn: I Beat AP/USA Today on Avodart Story
It's not often that I can say I beat a major publication to a pharma industry story, but it happened last week. I'm talking...
Viagra Print Ad Art Imitates Life as it Could be Without FDA Regulations
A new (to me) Viagra print ad caught my attention in this week's Business Week (or was it Newsweek?) magazine.The ad is an example...
New Privacy Rules in Economic Stimulus Law: Will They Restrict Certain Pharmaceutical Marketing Practices?
This article reviews the medical privacy restrictions included in the American Recovery and Reinvestment Act, which President Obama signed into law on Feb. 17, 2009, and discusses the impact these restrictions might have on pharmaceutical marketing.
FDA’s Use of Social Media: Peanuts Today, Drugs Tomorrow!
In the future, will the FDA also be pulled into social media by a major Rx drug recall? What can the drug industry learn from the FDA's use of social media and will FDA's example help guide the industry toward best practices in this area? This article describes FDA's social networking initiatives in context of these questions.
Will Healthcare be Rationed or Rational? A Case for Supporting Comparative Effectiveness Research
In this article, Kim Slocum, former Director, Strategic Planning & Business Development at AstraZeneca describes several alternative future health care system scenarios and makes a case for the industry to support Comparative Effectiveness Research or CER.
Pharma’s Bad Rep or Bad Rap: Whatever! The Drug Industry Must Earn Back the...
This article summarizes the results of the 'How to Earn Back the Public's Trust' survey hosted by Pharma Marketing News between February 4, 2009 and March 14, 2009 , including selected comments from respondents and other commentators.














